About us
Our expertise
Commercial >
We provide commercial consulting and advisory solutions across the product development and commercialization lifecycle.

Portfolio, Licensing & Development >

Commercialization & Growth >

Value, Pricing & Access >
Our expertise across scientific and commercial domains delivers a collaborative and bespoke approach to maximize patient access and the commercial success of your innovations.

Value, Pricing & Access Strategy >

HEOR Evidence Generation >

Evidence Synthesis & RWE Generation >

Medical & Scientific Affairs >
We provide world-class thought partnership and solutions that enhance the business impact of medical and scientific affairs.

Asset Development >

Launch Strategy >

Implementation & Impact >

Centers of Excellence >
Putnam’s Centers of Excellence allow us to dig deep, challenge convention, and take you further with strategies underpinned by technical expertise in cutting-edge topics.

Advanced Clinical Technologies >

Forecasting & Financial Modeling >

Integrated Insights >

Data Strategy, Analytics & AI >
Transform life sciences with AI-driven data strategies for impactful insights across the product lifecycle.

AI at Putnam

Data strategy

Integrated Advanced Analytics
AI at Putnam

Learn about our data strategy and analytics services for pharmaceutical companies in the life science industry.

Learn more
Join Putnam
Insights

Identifying micro-moments and how to leverage them

0 mins read

20 September 2022

Insights

More insights.

See all insights

Jump to a slide with the slide dots.

Insights from ISPOR Europe 2025

Key insights from ISPOR Europe 2025 on evolving HEOR, RWE, AI-driven evidence, patient-centered outcomes, and the future of market access.

Unpacking $100B+ Obesity Market Opportunity: What It Means for Biopharma, Payers, and Providers

As obesity care surges past $100B, biopharma, payers, and providers face a new era of opportunity.

ESMO 2025 Insights: Emerging oncology trends highlighting the need for Precision Medical Affairs

At ESMO 2025, science set the pace, but Precision Medical Affairs defined the path, turning complexity into clarity and innovation into impact.